| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
GDC-0449 |
FIMM |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.0037 |
1 |
| mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
1 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
1 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.0019 |
1 |